Evidence map›Paper›PMID 39228675›Full record

ArticleIJID regions2024

Acute Chagas disease outbreaks in Colombia in 2019.

Maryi Lorena Segura-Alba, Carolina Hernandez, Angela Patricia Guerra, Nicolas Luna, Liliana Jazmín Cortes, Claudia Rincón Acevedo, Natalia Ballesteros, Martha Stella Ayala, Mauricio Javier Vera, Ricardo Andrés Caicedo Diaz and 5 more

Abstract read
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Oral Route Infection byPathogens (Basel, Switzerland) · 2026
    Review
  2. Clinical Progression of Cardiac ChronicPathogens (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maryi Lorena Segura-AlbaGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Carolina HernandezCentro de Investigaciones en Microbiología y Biotecnología - UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
Angela Patricia GuerraGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Nicolas LunaCentro de Investigaciones en Microbiología y Biotecnología - UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
Liliana Jazmín CortesGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Claudia Rincón AcevedoGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Natalia BallesterosCentro de Investigaciones en Microbiología y Biotecnología - UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
Martha Stella AyalaGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Mauricio Javier VeraSubdirección de enfermedades transmisibles, Ministerio de Salud y Protección Social Bogotá, Colombia.
Ricardo Andrés Caicedo DiazDrugs for Neglected Diseases initiative-Latin America, Rio de Janeiro, Brazil.
Susanne Carolina ArdilaGrupo de Entomología, Instituto Nacional de Salud, Bogotá, Colombia.
Astrid Carolina FlórezGrupo de Parasitología, Instituto Nacional de Salud, Bogotá, Colombia.
Luz H PatiñoCentro de Investigaciones en Microbiología y Biotecnología - UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
Alberto E Paniz-MondolfiMolecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Juan David RamírezCentro de Investigaciones en Microbiología y Biotecnología - UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study seeks to address the critical knowledge gap surrounding the acute phase of Chagas disease in Colombia, with a specific focus on cases reported in 2019. The acute phase of Chagas disease is a pivotal period for intervention, yet it remains poorly understood, particularly in regions where oral transmission is presumed to be a significant factor. By analyzing these recent cases, our research aims to provide a deeper understanding of the dynamics of Chagas disease during its acute phase in Colombia in 2019. This understanding is essential not only for improving disease management and treatment strategies but also for enhancing public health responses to this neglected tropical disease. In particular, our study highlights the importance of identifying and addressing the unique challenges posed by oral transmission routes, which have been increasingly recognized within Colombia's Chagas disease landscape.

Indexed as

Acute Chagas diseaseColombiaOral transmissionOutbreaksTrypanosoma cruzi

Identifiers

PMID39228675
PMCPMC11369394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.